BioSpace News Archive

Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3, 2023, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting.

atai Life Sciences will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial Genomics Summit, September 19th.

Zomedica Corp. announced the commercial launch of its newest assay - endogenous ACTH for equine plasma - for the TRUFORMA In-Clinic Biosensor Testing Platform.

Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that on September 11, 2023, the Company’s Board of Directors (the “Board”) granted inducement awards consisting of non-qualified stock options to purchase 444,300 shares of common stock to seven new employees under the Company’s 2023 Inducement Plan.

23andMe Holding Co. and the non-profit Sickle Cell 101, have joined forces to expand awareness of people’s sickle cell carrier status.

Vincerx Pharma, Inc. today reported that the first patient has been dosed in the Phase 1 trial evaluating VIP943 in patients with relapsed/refractory acute myeloid leukemia (R/R AML), myelodysplastic syndrome (MDS), and B-cell acute lymphoblastic leukemia (B-cell ALL).

ECS , a leader in advanced technology, science, and engineering solutions, has named Jackie Fendrock vice president of Operations and Growth.

Aclipse Therapeutics announced today that it has signed an exclusive license agreement with Seoul, South Korea-based Chong Kun Dang Pharmaceutical Corporation (“CKD”).

Apogee Therapeutics, Inc. today announced that members of its management will participate in a fireside chat at the 2023 Stifel Virtual I&I Day on Wednesday, September 20th, 2023.